Picture of Sanofi SA logo

SAN — Sanofi SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: EU Approves Sanofi's Menquadfi To Treat Infants Against Invasive Meningococcal Disease

BRIEF-EU Approves Sanofi's Menquadfi To Treat Infants Against Invasive Meningococcal Disease

- Sanofi SA SASY.PA:

  • SANOFI’S MENQUADFI APPROVED IN THE EU FOR USE IN INFANTS FROM AGE SIX WEEKS AGAINST INVASIVE MENINGOCOCCAL DISEASE

Source text: ID:nGNX9bjW8t

Further company coverage: SASY.PA


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Sanofi SA

See all news